2025 Peking University Urology Academic Forum | Prof. Changwen Zhang (The Second Hospital of Tianjin Medical University)
Prof. Changwen Zhang presented a comprehensive update on the Chinese clinical exploration of ADC-based therapies in urothelial carcinoma. His presentation highlighted the promising role of Vedicitumab (RC48), a HER2-targeted ADC,…
Prof. Bing Wang Presents Single-Port Snake-Arm Robot Application in Urology at 2025 Peking University Urology Academic Forum
?si=Je3YthZKHfx0xBY3
2025 Peking University Urology Academic Forum | Prof. Shan Liu
In his insightful presentation, Prof. Shan Liu shared an in-depth look into China's rapidly evolving surgical robot ecosystem, highlighting the comprehensive technical support and advanced maintenance services provided for robotic…
Redefining Standards in Urothelial Cancer: A Conversation with Dr. Thomas Powles
In this exclusive UroStream interview, we had the privilege of speaking with Dr. Thomas Powles, MD, a leading oncologist at Barts Health NHS Trust and the global lead investigator of…
EAU 2025 | Professor Alicia K. Morgans: Challenges and Breakthroughs in Prostate Cancer Treatment
In this UroStream special from the 2025 EAU Congress, Professor Alicia K. Morgans from Dana-Farber Cancer Institute (USA) shares her expert insights into the evolving landscape of metastatic prostate cancer…
CUDA Yanqi Lake Meeting | Professor Liqun Zhou: Advancing the Diagnostic Frontier to Improve Survival in Chinese Prostate Cancer Patients
In recent years, the incidence of prostate cancer in China has continued to rise, creating an urgent need to improve diagnostic and treatment strategies tailored to this growing patient population. At the 5th Annual CUDA Yanqi Lake Meeting (2025), hosted by the Chinese Urological Doctor Association, UroStream invited Professor Liqun Zhou, Institute of Urology, Peking University, to discuss the importance of early screening, optimized diagnostic approaches, and advances in neoadjuvant therapy. His insights point toward practical steps for enhancing the survival and quality of life of prostate cancer patients in China.
EAU 2025 | Professor Renée C.A. Leenen Presents 20-Year ERSPC Follow-Up, Offering New Perspectives on Prostate Cancer Screening
At the 2025 Annual Meeting of the European Association of Urology (EAU), Professor Renée C.A. Leenen from Erasmus MC in Rotterdam, the Netherlands, presented the latest 20-year follow-up results from…